China Biologic Products (CBPO) Unit Receives China FDA Approval to Begin Human Coagulation Factor IX Trial
Tweet Send to a Friend
China Biologic Products, Inc. (Nasdaq: CBPO) announced that Shandong Taibang Biological Products Co. Ltd., the Company's majority-owned subsidiary, recently obtained ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE